218
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      T-bet controls regulatory T cell homeostasis and function during type-1 inflammation

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Several subsets of Foxp3 + regulatory T (T reg) cells work in concert to maintain immune homeostasis. However, the molecular bases underlying the phenotypic and functional diversity of T reg cells remain obscure. We show that in response to interferon-γ, Foxp3 + T reg cells upregulated the T helper 1 (T H1)-specifying transcription factor T-bet. T-bet promoted expression of the chemokine receptor CXCR3 on T reg cells, and T-bet + T reg cells accumulated at sites of T H1-mediated inflammation. Furthermore, T-bet expression was required for the homeostasis and function of T reg cells during type-1 inflammation. Thus, within a subset of CD4 + T cells, the activities of Foxp3 and T-bet are overlaid, resulting in T reg cells with unique homeostatic and migratory properties optimized for suppression of T H1 responses in vivo.

          Related collections

          Most cited references30

          • Record: found
          • Abstract: found
          • Article: not found

          Selective stimulation of T cell subsets with antibody-cytokine immune complexes.

          Interleukin-2 (IL-2), which is a growth factor for T lymphocytes, can also sometimes be inhibitory. Thus, the proliferation of CD8+ T cells in vivo is increased after the injection of a monoclonal antibody that is specific for IL-2 (IL-2 mAb), perhaps reflecting the removal of IL-2-dependent CD4+ T regulatory cells (T regs). Instead, we show here that IL-2 mAb augments the proliferation of CD8+ cells in mice simply by increasing the biological activity of preexisting IL-2 through the formation of immune complexes. When coupled with recombinant IL-2, some IL-2/IL-2 mAb complexes cause massive (>100-fold) expansion of CD8+ cells in vivo, whereas others selectively stimulate CD4+ T regs. Thus, different cytokine-antibody complexes can be used to selectively boost or inhibit the immune response.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses.

            In the course of infection or autoimmunity, particular transcription factors orchestrate the differentiation of T(H)1, T(H)2 or T(H)17 effector cells, the responses of which are limited by a distinct lineage of suppressive regulatory T cells (T(reg)). T(reg) cell differentiation and function are guided by the transcription factor Foxp3, and their deficiency due to mutations in Foxp3 results in aggressive fatal autoimmune disease associated with sharply augmented T(H)1 and T(H)2 cytokine production. Recent studies suggested that Foxp3 regulates the bulk of the Foxp3-dependent transcriptional program indirectly through a set of transcriptional regulators serving as direct Foxp3 targets. Here we show that in mouse T(reg) cells, high amounts of interferon regulatory factor-4 (IRF4), a transcription factor essential for T(H)2 effector cell differentiation, is dependent on Foxp3 expression. We proposed that IRF4 expression endows T(reg) cells with the ability to suppress T(H)2 responses. Indeed, ablation of a conditional Irf4 allele in T(reg) cells resulted in selective dysregulation of T(H)2 responses, IL4-dependent immunoglobulin isotype production, and tissue lesions with pronounced plasma cell infiltration, in contrast to the mononuclear-cell-dominated pathology typical of mice lacking T(reg) cells. Our results indicate that T(reg) cells use components of the transcriptional machinery, promoting a particular type of effector CD4(+) T cell differentiation, to efficiently restrain the corresponding type of the immune response.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells.

              IL-2(-/-) mice develop autoimmunity despite having relatively normal numbers of regulatory T cells (Tregs). In contrast, we demonstrate that IL-2(-/-) x IL-15(-/-) and IL-2Rbeta(-/-) mice have a significant decrease in Treg numbers. Ectopic expression of foxp3 in a subset of CD4(+) T cells rescued Treg development and prevented autoimmunity in IL-2Rbeta(-/-) mice, suggesting that IL-2Rbeta-dependent signals regulate foxp3 expression in Tregs. Subsequent analysis of IL-2Rbeta-dependent signal transduction pathways established that the transcription factor STAT5 is necessary and sufficient for Treg development. Specifically, T cell-specific deletion of STAT5 prevented Treg development; conversely, reconstitution of IL-2Rbeta(-/-) mice with bone marrow cells expressing an IL-2Rbeta mutant that exclusively activates STAT5 restored Treg development. Finally, STAT5 binds to the promoter of the foxp3 gene suggesting that IL-2Rbeta-dependent STAT5 activation promotes Treg differentiation by regulating expression of foxp3.
                Bookmark

                Author and article information

                Journal
                100941354
                21750
                Nat Immunol
                Nature immunology
                1529-2908
                1529-2916
                27 March 2009
                3 May 2009
                June 2009
                1 December 2009
                : 10
                : 6
                : 595-602
                Affiliations
                [1 ] Benaroya Research Institute, Seattle, WA 98101, USA
                [2 ] Department of Immunology, University of Washington School of Medicine, Seattle, WA 98195
                [3 ] Department of Peditrics, University of Washington School of Medicine, Seattle, WA 98195
                Author notes
                Correspondence should be addressed to D.J.C. (campbell@benaroyaresearch.org)

                Author Contributions. M.A.K., K.B.U. and D.J.C. designed the study, analyzed data and wrote the manuscript. M.A.K. and D.J.C. performed the experiments with assistance from N.R.P., J.R.K. and G.T-H.

                Author Information. The authors declare no competing financial interests.

                Article
                nihpa105940
                10.1038/ni.1731
                2712126
                19412181
                50095bb8-d234-400d-9d75-eb134e318813
                History
                Funding
                Funded by: National Institute of Allergy and Infectious Diseases Extramural Activities : NIAID
                Funded by: National Institute of Diabetes and Digestive and Kidney Diseases : NIDDK
                Award ID: R21 AI069889-02 ||AI
                Funded by: National Institute of Allergy and Infectious Diseases Extramural Activities : NIAID
                Funded by: National Institute of Diabetes and Digestive and Kidney Diseases : NIDDK
                Award ID: R01 DK072295-04 ||DK
                Funded by: National Institute of Allergy and Infectious Diseases Extramural Activities : NIAID
                Funded by: National Institute of Diabetes and Digestive and Kidney Diseases : NIDDK
                Award ID: R01 AI067750-03 ||AI
                Categories
                Article

                Immunology
                Immunology

                Comments

                Comment on this article